Floxuridine / floxuridine FDA New drug application 075387 international drug patent coverage, generic alternatives and suppliers

Generated: August 24, 2017

NDA 075387 describes FLOXURIDINE, which is a drug marketed by Fresenius Kabi Usa and West-ward Pharms Int and is included in two NDAs. It is available from one supplier. Additional details are available on the FLOXURIDINE profile page.

The generic ingredient in FLOXURIDINE is floxuridine. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the floxuridine profile page.

Summary for NDA: 075387

Tradename:	1
Applicant:	1
Ingredient:	1
Patents:	0
Formulation / Manufacturing:	see details

Summary for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	500MG/VIAL
Approval Date:	Apr 16, 2000	TE:	AP	RLD:	No

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.